Dr. Husam I. Issa, MD

Dr. Issa practices at Cls Health in Webster, Texas.

Dr. Issa's NPI, 1821064304, was assigned on February 24, 2006. Dr. Issa graduated from University of Jordan Faculty of Medicine in 1995. Dr. Issa's Texas license number on file is N0849.

Dr. Issa's primary practice is Cls Health, at 500 N Kobayashi Rd, Webster, TX 77598 in Harris County. The practice phone is (281) 724-1860.

Dr. Issa's primary practice is Cls Health in Webster, Texas. Dr. Issa is also affiliated with HCA Houston Healthcare Clear Lake. The medical group on file is CLS Health. Dmand AI also links Dr. Issa to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Issa practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Issa's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Issa is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Issa's licenses on file in 4 states: Texas, Rhode Island, Massachusetts and Pennsylvania.

Dmand AI lists acute skin infection, hiv/aids, joint or bone infection, pneumonia and UTI among the conditions Dr. Issa treats.

CMS data shows 7,246 Medicare services from Dr. Issa across 14 procedure codes in 2024, for 496 Medicare patients. Medicare paid $155,321 for them.

CMS counts 496 Medicare patients who saw Dr. Issa in 2024. The largest group is 65 to 74, with 176 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Issa's median patient age at 70, with 52% women.

In 2024, Dr. Issa wrote 659 Medicare Part D claims for 179 patients. 69% of them were for generic drugs. CMS names the drug for 491 of them, across 17 drugs with 11 or more claims each, at $612,361 in total drug cost. In 2023, CMS named 433 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Issa for performance year 2024, reported individually. Dr. Issa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Issa in 2018. Dr. Issa's most frequent co-authors are Georges Z. Markarian, MD, Faris J. Shweikeh, MD and Mohammed Jamal Shweikeh, MD.

Dmand AI links Dr. Issa to 2 clinical trials. Conditions studied include COVID-19 and Pneumonia, Viral. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Issa that name 2 trials.

CMS Open Payments shows 265 general payments to Dr. Issa from 29 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 84% of the total. Allergan Inc. paid the most, $38,370. It also lists 13 research payments totaling $270,478 from 2020 to 2022, naming 2 clinical trials.

Dr. Issa graduated from University of Jordan Faculty of Medicine in 1995. Dr. Issa is a member of IDSA.

Dr. Issa is in network with 23 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.